KYMR
Kymera Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$115.01-0.66%
Price as of Jul 20, 2026
KYMR ownership
Kymera Therapeutics, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
173
Net (3m)
-$398.8M
Insider trades by month Buys Sells
Apr
May
Jun
Jul
Context3-month price +33.2%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 7, 2026 | Mainolfi Nellodirector, officer: Chief Executive Officer | Sell | 50,000 | $119.00 |
| Jul 7, 2026 | Mainolfi Nellodirector, officer: Chief Executive Officer | Option | 4,441 | $2.08 |
| Jul 7, 2026 | Mainolfi Nellodirector, officer: Chief Executive Officer | Option | 50,000 | $2.08 |
| Jul 7, 2026 | Mainolfi Nellodirector, officer: Chief Executive Officer | Option | 45,559 | $2.08 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 770 | $105.78 |
| Jul 2, 2026 | Jacobs Bruce N.officer: Chief Financial Officer | Sell | 6,153 | $116.99 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 2,698 | $107.76 |
| Jul 2, 2026 | Jacobs Bruce N.officer: Chief Financial Officer | Sell | 51,375 | $114.77 |
| Jul 2, 2026 | Mainolfi Nellodirector, officer: Chief Executive Officer | Sell | 6,626 | $113.98 |
| Jul 2, 2026 | Jacobs Bruce N.officer: Chief Financial Officer | Sell | 7,971 | $115.82 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 10,848 | $108.28 |
| Jul 2, 2026 | Jacobs Bruce N.officer: Chief Financial Officer | Sell | 4,110 | $114.19 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 130 | $111.20 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 5,549 | $105.78 |
| Jul 2, 2026 | Jacobs Bruce N.officer: Chief Financial Officer | Sell | 3,200 | $117.70 |
| Jul 2, 2026 | Mainolfi Nellodirector, officer: Chief Executive Officer | Sell | 1,883 | $112.80 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 7,723 | $110.67 |
| Jul 2, 2026 | Jacobs Bruce N.officer: Chief Financial Officer | Sell | 1,100 | $112.79 |
| Jul 2, 2026 | Mainolfi Nellodirector, officer: Chief Executive Officer | Sell | 3,336 | $116.56 |
| Jul 2, 2026 | Jacobs Bruce N.officer: Chief Financial Officer | Sell | 1,700 | $111.57 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 2,133 | $106.63 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 934 | $111.20 |
| Jul 2, 2026 | Jacobs Bruce N.officer: Chief Financial Officer | Option | 61,378 | $5.33 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 14,798 | $106.63 |
| Jul 2, 2026 | Mainolfi Nellodirector, officer: Chief Executive Officer | Sell | 44,050 | $115.69 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 19,419 | $107.76 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 1,104 | $109.75 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 1,078 | $110.67 |
| Jul 2, 2026 | Booth Brucedirector | Sell | 1,498 | $108.28 |
| Jul 2, 2026 | Mainolfi Nellodirector, officer: Chief Executive Officer | Sell | 24,105 | $114.96 |
Source: KYMR SEC Form 4 filings, latest Jul 7, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their KYMR positions over the last 6 months (SEC Form 13F).
Increased
202
New positions
105
Reduced
145
Sold out
64
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 11.7M | May 15, 2026 |
| FMR LLC | Increased | 8.9M | Feb 17, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 8.7M | Feb 17, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 8.7M | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 7.5M | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | Increased | 7.5M | Mar 16, 2026 |
| VANGUARD GROUP INC | Increased | 6.3M | Jan 29, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 6.2M | Feb 17, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 6.1M | May 15, 2026 |
| BVF INC/IL | Unchanged | 5.5M | May 15, 2026 |
| BVF INC/IL | Unchanged | 5.5M | Feb 17, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 5.5M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 5.1M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 5.0M | Feb 12, 2026 |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | Reduced | 4.7M | Feb 13, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.